Search research articles
Contact Us
Filters
Showing results (51-60 of 138) with videos related to
Page
of 14
Sort By:
Breast Cancer Research : BCR
|
April 3, 2007
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh, Andrew R Green, Maryou B K Lambros, et al.
Frontiers in Oncology
|
May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Cancers
|
May 4, 2026
Efficacy and Safety of Oral Progestogens (Megestrol Acetate and Medroxyprogesterone Acetate) in Heavily Pretreated Oestrogen Receptor-Positive Metastatic Breast Cancer: A 10-Year Multi-Site Study
Iseult M Browne, Heng Chun Wong, Tazia Irfan, et al.
Journal of the National Cancer Institute
|
September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
Ben O'Leary, Rosalind J Cutts, Xin Huang, et al.
The Oncologist
|
September 28, 2013
DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes
Libero Santarpia, Takayuki Iwamoto, Angelo Di Leo, et al.
Clinical Chemistry
|
September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis
Ben O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo
Rachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
The New England Journal of Medicine
|
June 2, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C Turner, Jungsil Ro, Fabrice André, et al.
Breast Cancer Research and Treatment
|
August 17, 2022
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital
Niamh Cunningham, Scott Shepherd, Kabir Mohammed, et al.
The Oncologist
|
May 26, 2021
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3
Hope S Rugo, Massimo Cristofanilli, Sybille Loibl, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 138) with videos related to
Sort By:
Page
of 14
Breast Cancer Research : BCR
|
April 3, 2007
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh, Andrew R Green, Maryou B K Lambros, et al.
Frontiers in Oncology
|
May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Cancers
|
May 4, 2026
Efficacy and Safety of Oral Progestogens (Megestrol Acetate and Medroxyprogesterone Acetate) in Heavily Pretreated Oestrogen Receptor-Positive Metastatic Breast Cancer: A 10-Year Multi-Site Study
Iseult M Browne, Heng Chun Wong, Tazia Irfan, et al.
Journal of the National Cancer Institute
|
September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
Ben O'Leary, Rosalind J Cutts, Xin Huang, et al.
The Oncologist
|
September 28, 2013
DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes
Libero Santarpia, Takayuki Iwamoto, Angelo Di Leo, et al.
Clinical Chemistry
|
September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis
Ben O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo
Rachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
The New England Journal of Medicine
|
June 2, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C Turner, Jungsil Ro, Fabrice André, et al.
Breast Cancer Research and Treatment
|
August 17, 2022
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital
Niamh Cunningham, Scott Shepherd, Kabir Mohammed, et al.
The Oncologist
|
May 26, 2021
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3
Hope S Rugo, Massimo Cristofanilli, Sybille Loibl, et al.
Page
of 14